Conference abstract · 24 Sep 2015
Conference abstractPublished 25 Jan 2019
Endotherapy in refractory/PPI dependant GERD
Asian Institute of Gastroenterology, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Gastro-esophageal reflux disease (GERD), affects one third of the population worldwide and prevalence in India ranges between 8 to 19%. Majority of the patients have impaired Quality of Life (QOL) due to symptoms such as heartburn, regurgitation or dysphagia and the long term complications associated with it. Current treatments modalities include lifestyle modifications, long term pharmacological therapies, surgical fundoplication and more recently, endoscopic procedures. About 10% of patients with endoscopically proven reflux esophagitis are resistant to Proton Pump Inhibitors (PPIs). Further, almost 20% of patients have inadequate symptom control resulting in heartburn and regurgitation that cause detrimental effects on the quality of life. Also, potential side effects of long-term PPIs use (B12 deficiency; iron deficiency; hypomagnesaemia; increased susceptibility to pneumonia; enteric infections; fractures and hyper-gastrinemia), results in many patients discontinuing treatment. Surgical options for GERD have their limitations due to increased costs, hospitalization, complication rates and delayed recovery. Data from 5 year LOTUS study suggests that 15–20% of patients who have undergone fundoplication may have GERD symptoms. Uncontrolled GERD leading to acid induced non-cardiac chest pain results in a significant decrease in quality of life, productivity at work and economic burden on the patients. In addition, it is associated with worrisome complications such as strictures, Barrett’s esophagus and esophageal adenocarcinoma. The rising concern of long term side effects of the popular proton-pump inhibitors and the more recent evidence raising doubts about the durability of fundoplication have spurred re-interest in endoscopic procedures such as Stretta, GERD-X etc. to treat reflux disorder. Several clinical studies including a systematic review showed that the Stretta procedure improves GERD symptoms, quality of life and esophageal acid exposure and eliminates the need for anti-secretory drugs in majority of patients.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 25 Aug 2015
Refractory GERD Treatment
Research article · 7 Aug 2017
A Young Patient with Refractory Multiple Myeloma and Dialysis-Dependent Renal Failure has been Cured by Non-Cryopreserved Autologous Stem Cell Transplantation Followed by Live-Related Kidney Transplantation
Conference abstract · 27 Apr 2015
Successful treatment of steroid dependent refractory recurrent pericarditis in two adults with anti interleukin-1 antibody anakinra
Research article · 2 Jul 2021
Role of Pancreatic Endotherapy in children
More from this journal
The newest in Journal of Gastrointestinal & Digestive System.
Research article · 1 Jan 2026
Prospective Observational Study for the Evaluation of Efficacy and Safety Profile of Probiotics Food Supplement in Children with Acute Diarrhea
Case report · 11 Nov 2025
Bitter Guard: A Gut Wrenching Surprise
Research article · 18 Jun 2025
Ursodeoxycholic Acid Treatment of LPAC Presenting as Post Cholecystectomy Pain: Rationale and Design of a Randomised Trial
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Gastrointestinal & Digestive System
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Rakesh kalapala”
